Discover how Skinopathy’s GetSkinHelp app is transforming skin cancer screening and fast-track treatment. Access ...

Breaking down the settlement [PDF], Fred Hutch will pay around $11.5 million in cash to members of the class action, roughly ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

Phase III progression-free survival data were positive for first-line Braftovi in first-line combination therapy for mCRC.

While the medicine is free on the NHS in England for men with advanced prostate cancer, Giles has spent £20,000 on it. He ...

Merck KGaA’s antibody-drug conjugate (ADC), precemtabart tocentecan, has shown to be safe and tolerable in a Phase Ib trial.

A new State of Drug Access report shows that more than 40% of people living in the US could not afford their prescribed drugs ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...